6-chloro-2-(1-piperazinyl)pyrazine has been researched along with 5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole in 6 studies
| Studies (6-chloro-2-(1-piperazinyl)pyrazine) | Trials (6-chloro-2-(1-piperazinyl)pyrazine) | Recent Studies (post-2010) (6-chloro-2-(1-piperazinyl)pyrazine) | Studies (5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole) | Trials (5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole) | Recent Studies (post-2010) (5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole) |
|---|---|---|---|---|---|
| 157 | 8 | 24 | 218 | 0 | 12 |
| Protein | Taxonomy | 6-chloro-2-(1-piperazinyl)pyrazine (IC50) | 5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 5.4 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 5.4 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0107 | |
| 5-hydroxytryptamine receptor 1D | Homo sapiens (human) | 0.039 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.295 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.004 | |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 5.4 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.079 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Audia, JE; Baez, M; Cohen, ML; Kursar, JD; Lucaites, VL; Nelson, DL; Nissen, JS; Schenck, KW; Wainscott, DB | 1 |
| Benwell, K; Bickerdike, M; Kennett, G; Knight, AR; Misra, A; Quirk, K; Revell, D | 1 |
| Cooper, SJ; Neill, JC | 1 |
| Bethea, CL; Lorens, SA; Urban, JH; Van de Kar, LD | 1 |
| Jørgensen, H; Knigge, U; Warberg, J | 1 |
| Rabin, RA; Winter, JC | 1 |
6 other study(ies) available for 6-chloro-2-(1-piperazinyl)pyrazine and 5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole
| Article | Year |
|---|---|
Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.
Topics: Animals; Binding Sites; Cell Line; Cloning, Molecular; Gastric Fundus; Inositol 1,4,5-Trisphosphate; Male; Muscle Contraction; Muscle, Smooth; Radioligand Assay; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Temperature | 1993 |
Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
Topics: Binding Sites; Binding, Competitive; Cell Line; Humans; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Recombinant Proteins; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2004 |
Selective reduction by serotonergic agents of hypertonic saline consumption in rats: evidence for possible 5-HT1C receptor mediation.
Topics: Animals; Dose-Response Relationship, Drug; Drinking Behavior; Fenfluramine; Fluoxetine; Hypertonic Solutions; Indoles; Male; Piperazines; Pyrazines; Quinoxalines; Quipazine; Rats; Receptors, Serotonin; Serotonin | 1989 |
Effect of selective serotonin (5-HT) agonists and 5-HT2 antagonist on prolactin secretion.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Ergolines; Fenfluramine; Indoles; Male; Prolactin; Pyrazines; Radioimmunoassay; Rats; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Tetrahydronaphthalenes | 1989 |
Effect of selective serotonin receptor agonists on prolactin secretion in male rats.
Topics: Animals; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Indoles; Male; Prolactin; Pyrazines; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists | 1993 |
Discriminative stimulus properties of m-chlorophenylpiperazine.
Topics: Animals; Discrimination Learning; Generalization, Stimulus; Indoles; Male; Piperazines; Pyrazines; Rats; Rats, Inbred F344; Serotonin Antagonists; Serotonin Receptor Agonists | 1993 |